Back To Top

Tip: To quickly find your search term on this page, press "Ctrl" + "f" on your keyboard (Command + "f" on a Mac) and use the find bar.
S-49076 Catalog#: A-1281
         S-49076 is a novel, potent MET, FGFR1/2/3 and AXL tyrosine kinase inhibitor.
S-63845 Catalog#: A-6044
         S-63845 is a small molecule MCL1 inhibitor.
S-Ornidazole Catalog#: A-9042
SAHA (Vorinostat) Catalog#: A-1041
         SAHA is an HDAC inhibitor and shows IC 50 of 10 nM (HDAC-1) and 300 nM (rat liver HDAC)
SAR-245408(XL-147) Catalog#: A-1052
         SAR-245409(XL-147) is a PI3k inhibitor in clinical trials.
SAR-245409(XL-765) Catalog#: A-1068
         SAR-245409(XL-765) is a PI3K/mTOR inhibitor in clinical trials;
SAR-260301 Catalog#: A-1311
         PI3K inhibitor
SB-1518 Catalog#: A-1136
         SB-1518 is a JAK2 inhibitor.
SB-216763 Catalog#: A-1042
SB-431542 Catalog#: A-1043
         SB-431542 is a potent and selective inhibitor of transforming growth factor superfamily type I activin receptor-like kinase (ALK) receptors.
SB-939 Catalog#: A-1185
         SB-939 is a novel histone deacetylase (HDAC) inhibitor.
SCH-727965 Catalog#: A-1075
         SCH-727965 is a CDK inhibitor in clinical trials
SCH-772984 Catalog#: A-1333
         SCH772984 is a novel and selective inhibitor of ERK1/2. SCH-772984 effectively inhibits MAPK signaling and cell proliferation in BRAF or MEK inhibitor resistant models.
SCH-900776 Catalog#: A-1202
         SCH 900776 is a potent and selective CHK1 inhibitor with IC50 of 3 nM, 0.16 and 1.5 μM for CHK1, CDK2 and CHK2, respectively.
Seliciclib Catalog#: A-1282
         Seliciclib (CYC202 or R-roscovitine) is a potent inhibitor of CDK (cyclin dependent kinases) including CDK2/cyclin E, CDK7/cyclin H and CDK9/cyclin T. Seliciclib induces cell apoptosis.
Semagacestat (LY450139) Catalog#: A-1952
         Semagacestat (LY450139) is an blocker of γ-secretase for Aβ42, Aβ40 and Aβ38 with IC50 of 10.9 nM, 12.1 nM and 12.0 nM, also inhibits Notch signaling with IC50 of 14.1 nM.
SGI-110 Catalog#: A-1294
         SGI-110 is a proprietary dinucleotide pro-drug of decitabine which is a second generation DNA methyltransferase inhibitor.
SGI-1776 Catalog#: A-1102
         SGI-1776 is a PIM kinase inhibitor in clinical trials
SGI-7079 Catalog#: A-1280
         SGI-7079 is an Axl kinase inhibitor.
SGX-523 Catalog#: A-1060
         SGX523 is an orally bioavailable Met inhibitor
Silmitasertib Catalog#: A-1211
         Silmitasertib is an orally bioavailable small-molecule inhibitor of CK2 with potential antineoplastic activity.
Silymarin Catalog#: A-3014
Simeprevir Sodium Catalog#: A-9004
         Simeprevir Sodium
SN-38 Catalog#: A-2009
         Active metabolite of CPT-11 that inhibits DNA topoisomerase I (IC50 values are 0.74 and 1.9 μM in P388 and Ehrlich cells respectively).
Sofosbuvir Catalog#: A-9001
         Sofosbuvir, also known as PSI-977 and GS7977 (brand names Sovaldi and Virunon), is a drug used for hepatitis C virus (HCV) infection, with a high cure rate.
Sorafenib (BAY 43-9006) Catalog#: A-1044
Soy isoflavone Catalog#: A-3015
SR-13668 Catalog#: A-
         SR13668, an orally active Akt/PKB pathway inhibitor, has demonstrated cancer chemopreventive potential in preclinical studies.
STA-9090 Catalog#: A-1179
         STA-9090 is an HSP-90 inhibitor.
Strychnine Catalog#: A-3016
         Strychnine is one of the most bitter substances known
Sutent Catalog#: A-1045
         Sunitinib (marketed as Sutent, and previously known as SU11248) is an oral RTK inhibitor that was approved by the FDA

*Note: These products are for research purposes only, not for human consumption.